RS56460B1 - Topikalna supstanca koja sadrži botulinski toksin i boju - Google Patents

Topikalna supstanca koja sadrži botulinski toksin i boju

Info

Publication number
RS56460B1
RS56460B1 RS20171000A RSP20171000A RS56460B1 RS 56460 B1 RS56460 B1 RS 56460B1 RS 20171000 A RS20171000 A RS 20171000A RS P20171000 A RSP20171000 A RS P20171000A RS 56460 B1 RS56460 B1 RS 56460B1
Authority
RS
Serbia
Prior art keywords
dye
botulinum toxin
topical composition
topical
composition
Prior art date
Application number
RS20171000A
Other languages
English (en)
Inventor
Jacob Waugh
Curtis Ruegg
Original Assignee
Revance Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46457668&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS56460(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Revance Therapeutics Inc filed Critical Revance Therapeutics Inc
Publication of RS56460B1 publication Critical patent/RS56460B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation
RS20171000A 2011-01-07 2011-12-22 Topikalna supstanca koja sadrži botulinski toksin i boju RS56460B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161430868P 2011-01-07 2011-01-07
PCT/US2011/066728 WO2012094163A1 (en) 2011-01-07 2011-12-22 Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositions

Publications (1)

Publication Number Publication Date
RS56460B1 true RS56460B1 (sr) 2018-01-31

Family

ID=46457668

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20171000A RS56460B1 (sr) 2011-01-07 2011-12-22 Topikalna supstanca koja sadrži botulinski toksin i boju

Country Status (17)

Country Link
US (3) US20140154237A1 (sr)
EP (2) EP3248614A1 (sr)
JP (4) JP6444032B2 (sr)
BR (1) BR112013017311A2 (sr)
CY (1) CY1119427T1 (sr)
DK (1) DK2661276T3 (sr)
ES (1) ES2641068T3 (sr)
HK (1) HK1247553A1 (sr)
HR (1) HRP20171483T1 (sr)
HU (1) HUE035057T2 (sr)
LT (1) LT2661276T (sr)
NO (1) NO2661276T3 (sr)
PL (1) PL2661276T3 (sr)
PT (1) PT2661276T (sr)
RS (1) RS56460B1 (sr)
SI (1) SI2661276T1 (sr)
WO (1) WO2012094163A1 (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102499981B (zh) * 2005-03-03 2016-08-03 雷文斯治疗公司 用于局部施用和经皮肤递送肉毒杆菌毒素的组合物和方法
HUE037595T2 (hu) 2008-12-31 2018-09-28 Revance Therapeutics Inc Injektálható botulinum toxin készítmények
MX344583B (es) 2009-06-25 2016-12-20 Revance Therapeutics Inc Formulaciones de toxina botulinica libres de albumina.
JP2015514074A (ja) * 2012-03-22 2015-05-18 ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 局所化学的神経麻痺薬を使用して皺を処置する方法
KR20180077202A (ko) * 2015-10-29 2018-07-06 레반스 테라퓨틱스, 아이엔씨. 주사용 보툴리눔 독소 제제 및 긴 지속기간의 치료적 또는 미용적 효과를 갖는 이를 이용한 방법
US10369190B2 (en) 2016-09-13 2019-08-06 Allergan, Inc. Non-protein clostridial toxin compositions
EP3624819A4 (en) * 2017-05-18 2021-03-24 Revance Therapeutics, Inc. METHOD OF TREATMENT OF CERVICAL DYSTONIA
WO2019046311A1 (en) 2017-08-28 2019-03-07 Revance Therapeutics, Inc. TRANSMUCOSAL COMPOSITIONS OF BOTULINUM TOXIN, KITS AND METHODS FOR TREATING BLADDER DISORDERS
US20210321696A1 (en) * 2020-04-20 2021-10-21 First Step Holdings, Llc Covid mask

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286016A (en) * 1979-04-12 1981-08-25 The Drackett Company Pouch bleach
US4797128A (en) 1984-12-10 1989-01-10 Quadrex Hps, Inc. Method of and apparatus for cleaning garments and soft goods contaminated with nuclear, chemical and/or biological contaminants
US5877278A (en) 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5624636A (en) * 1994-11-07 1997-04-29 Univ. Of Texas Board Of Regents Hypochlorite based disinfectant for dental impressions
US6444209B1 (en) 1996-10-28 2002-09-03 Wisconsin Alumni Research Foundation Hybrid botulinal neurotoxins
US6566574B1 (en) * 1998-06-30 2003-05-20 Sandia Corporation Formulations for neutralization of chemical and biological toxants
US6417423B1 (en) * 1998-09-15 2002-07-09 Nanoscale Materials, Inc. Reactive nanoparticles as destructive adsorbents for biological and chemical contamination
GB2386246B (en) 2001-11-01 2005-06-29 Marconi Applied Techn Ltd Electron beam tube apparatus
US6706092B2 (en) * 2002-04-17 2004-03-16 Alliedsignal Inc. Chemical/Biological decontamination filter
US7582595B1 (en) 2002-11-06 2009-09-01 Taylor Lawnie H Hypochlorous acid/alkali metal hydoxide-containing products, methods and equipment for removing stains from fabrics
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
US7776292B2 (en) * 2004-01-16 2010-08-17 Cdic, Inc. Method and apparatus for bioweapon decontamination
MXPA06009898A (es) * 2004-03-03 2008-02-07 Revance Therapeutics Inc Composiciones y metodos para la aplicacion topica y suministro transdermico de toxinas botulinicas.
JP4730304B2 (ja) * 2004-05-20 2011-07-20 和光純薬工業株式会社 ヒアルロン酸バインディングプロテインを用いたヒアルロン酸の測定方法
US20080220021A1 (en) 2005-02-14 2008-09-11 Pankaj Modi Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
CN102499981B (zh) * 2005-03-03 2016-08-03 雷文斯治疗公司 用于局部施用和经皮肤递送肉毒杆菌毒素的组合物和方法
US20070154493A1 (en) * 2005-12-30 2007-07-05 Judy Hattendorf Method of treating skin needing botulinum toxin type a treatment
CN101484142B (zh) * 2006-03-24 2013-06-05 奥克思利尤姆国际控股公司 包含对碱性不稳定的药物的稳定组合物
WO2008105773A2 (en) * 2006-03-31 2008-09-04 Massachusetts Institute Of Technology System for targeted delivery of therapeutic agents
DE102006019447A1 (de) * 2006-04-24 2007-10-25 Dressler, Dirk, Dr. Markierung von Botulinum Toxin
WO2008101098A2 (en) * 2007-02-15 2008-08-21 Allergan, Inc. Use of botulinum toxin and enzymes for treating bladder or prostata disorders, or hyperhydrosis
CA2678366C (en) * 2007-03-06 2013-11-19 Steris Inc. Transportable decontamination unit and decontamination process
JP2009001423A (ja) * 2007-05-21 2009-01-08 Life:Kk 感染性廃棄物用回収袋又は容器および感染性廃棄物処理方法
WO2009042165A2 (en) * 2007-09-25 2009-04-02 Thomas Jefferson University Mutant botulinum neurotoxin serotype a polypeptide and uses thereof
US20090148342A1 (en) * 2007-10-29 2009-06-11 Bromberg Steven E Hypochlorite Technology
US20090250626A1 (en) * 2008-04-04 2009-10-08 Hexatech, Inc. Liquid sanitization device
HUE037595T2 (hu) * 2008-12-31 2018-09-28 Revance Therapeutics Inc Injektálható botulinum toxin készítmények
MX344583B (es) 2009-06-25 2016-12-20 Revance Therapeutics Inc Formulaciones de toxina botulinica libres de albumina.

Also Published As

Publication number Publication date
JP2014502969A (ja) 2014-02-06
JP2020172519A (ja) 2020-10-22
BR112013017311A2 (pt) 2016-10-04
JP6444032B2 (ja) 2018-12-26
JP2018188447A (ja) 2018-11-29
HRP20171483T1 (hr) 2017-12-01
HUE035057T2 (en) 2018-05-02
EP2661276B1 (en) 2017-08-02
EP2661276A1 (en) 2013-11-13
LT2661276T (lt) 2017-12-11
EP3248614A1 (en) 2017-11-29
EP2661276A4 (en) 2014-09-03
PL2661276T3 (pl) 2018-03-30
WO2012094163A1 (en) 2012-07-12
US20140154237A1 (en) 2014-06-05
JP6605420B2 (ja) 2019-11-13
CY1119427T1 (el) 2018-03-07
US20210189326A1 (en) 2021-06-24
SI2661276T1 (sl) 2017-12-29
PT2661276T (pt) 2017-10-06
NO2661276T3 (sr) 2017-12-30
US20120294844A1 (en) 2012-11-22
HK1247553A1 (zh) 2018-09-28
JP2017025083A (ja) 2017-02-02
ES2641068T3 (es) 2017-11-07
DK2661276T3 (en) 2017-10-02

Similar Documents

Publication Publication Date Title
LT2661276T (lt) Paviršinio naudojimo kompozicija, apimanti botulino toksiną ir dažą
CO6821888A2 (es) Preperación de liofilizada de toxina botullinica
IL231817B (en) Split Inteins and their uses
PL2691443T3 (pl) Sprzężone lipomery i ich zastosowania
EP2914608A4 (en) ELECTROCHROMIC COMPOUND, ELECTROCHEMICAL COMPOSITION AND DISPLAY ELEMENT
EP2785208A4 (en) DESIGN AND PREPARATION OF A SWIM SUIT
GB201115904D0 (en) Advertisements in view
GB2503172B (en) Split gate valve
HK1212898A1 (zh) 酮洛芬的局部組合物
HK1194143A1 (zh) 非- 肉毒梭菌測定法
HK1190713A1 (zh) 外用抗真菌劑
GB2507799B (en) Improvements in or relating to gate valves
PT2626605E (pt) Válvula com um canal de derivação
EP2762129A4 (en) COSMETIC COMPOSITION AND COSMETIC PRODUCT
ZA201306985B (en) A sunscreen composition
ZA201306442B (en) Chop gate and nozzle
EP2788389A4 (en) PHOTOCURABLE COMPOSITION AND METHOD FOR FORMING A PATTERN
EP2888365A4 (en) NOVEL TOXIN IN CLOSTRIDIUM PERFRINGENS TYPE A
GB201106357D0 (en) Composition and uses thereof
GB2501272B (en) Gate Valve
BR112013031220A2 (pt) composição tópica
HK1212238A1 (en) Compositions comprising substituted phenols and topical application thereof
GB2501710B (en) Improvements in valves
PT2511347T (pt) Corante reativo
EP2895962A4 (en) REVERSE ADVERTISEMENTS